Research Studies » Investigational Varicella Vaccine

Qualification:
●Your infant is 12 to 15 months of age
●Your infant has not yet received any of the four vaccines commonly administered in the US between 12 and 15 months: chickenpox (varicella), MMR (Priorix), pneumococcal (Prevnar-20), or Hepatitis A (Havrix).

Qualified participants will receive:
●Compensation: Get compensated up to $100 per clinic visit with no cost to you or your insurance!
●Comprehensive Support: Regular check-ins and assessments to ensure your health is a priority. Our trial is conducted by experienced healthcare professionals dedicated to your well-being.
●No-cost vaccines: all qualifying participants will receive FDA-approved vaccines for MMR (Priorix), pneumococcal (Prevnar-20), or Hepatitis A (Havrix).  Additionally, half of the participants will receive the FDA-approved vaccine Varivax against chickenpox, and the other half will receive the investigational varicella vaccine that is being studied.

Powered By RealTime-CTMS Clinical Trial Management System